logo
logo

Avive Secures $22 Million In Series A Funding To Advance Intelligent Aed And Lifesaving Platform For Out-Of-Hospital Cardiac Arrest

Avive Secures $22 Million In Series A Funding To Advance Intelligent Aed And Lifesaving Platform For Out-Of-Hospital Cardiac Arrest

03/16/22, 8:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Money raised
$22 million
Round Type
series a
Avive Solutions, Inc., developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, today announced that it closed a $22 million Series A round of financing co-led by Questa Capital, Catalyst Health Ventures and repeat investor Laerdal Million Lives Fund. This funding will be used to advance a new technology-enabled approach for improving OHCA survival rates. Ryan Drant, founder and managing partner of Questa Capital, and Darshana Zaveri, managing partner of Catalyst Health Ventures, both joined the Avive board in connection with the financing.

Company Info

Company
Avive Solutions
Location
san francisco, california, united states
Additional Info
Avive is a San Francisco-based healthcare technology company that is bringing to market a revolutionary connected automated external defibrillator (AED), coupled with a first of its kind software platform to address the massive healthcare problem of out-of-hospital cardiac arrest (OHCA). Avive's connected hardware and software platform will integrate with the existing public safety and provider ecosystems to create a comprehensive OHCA response solution, with the goal of significantly increasing survival rates from cardiac arrest emergencies. To learn more about Avive and its life-saving solutions, visit www.avive.life. SOURCE Avive